BridgeBio Pharma, Inc.
← Back to BBIO Overview

BridgeBio Pharma, Inc. (BBIO)

Profitability & Net Margin History

Current Net Margin

-127.93%

BridgeBio Pharma, Inc. currently has a net profit margin of -127.93%.

Financial Fundamentals

BBIOQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.15-0.20-127.93%2348
2025-09-300.12-0.18-151.40%1312
2025-06-300.11-0.18-164.52%2098
2025-03-310.12-0.17-143.55%436257
2024-12-310.01-0.27-4506.12%142507
2024-09-300.00-0.16-5931.19%254299
2024-06-300.00-0.07-3388.19%337151
2024-03-310.21-0.04-16.68%961931
2023-12-310.00-0.17-9635.99%530944
2023-09-300.00-0.18-4326.55%529557
2023-06-300.00-0.16-9622.12%194655
2023-03-310.00-0.14-7675.58%31777
2022-12-310.00-0.14-7357.81%3327503
2022-09-300.00-0.14-40632.84%4061948
2022-06-300.07-0.01-13.36%1158032
2022-03-310.00-0.20-11593.68%1045154
2021-12-310.01-0.15-1142.15%551037
2021-09-300.00-0.16-6652.52%647417
2021-06-300.05-0.10-178.34%3512014
2021-03-310.00-0.16-35298.48%6304660
2020-12-310.00-0.12-98345.08%9691948
2020-09-300.01-0.12-1425.61%
2020-06-300.00-0.12
2020-03-310.00-0.09
2019-12-310.01-0.07-531.57%30727
2019-09-300.03-0.06-224.30%
2019-06-300.00-0.07
2019-03-310.00-0.06
2018-12-310.00-0.04
2018-09-300.00-0.03
2018-06-300.00-0.03
2018-03-310.00-0.03

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.